drugset / Trial / NCT00354276
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as VNP40101M and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving VNP40101M followed by cytarabine may kill more cancer cells. PURPOSE: This phase II trial is studying how well VNP40101M followed by cytarabine works in treating older patients with acute myeloid leukemia.
Timeline
- Start
- 2006-05
- Primary completion
- 2008-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | — | Intravenous |
| Subject | laromustine | Other / unclassified | — | Intravenous |